OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Suvorexant for the prevention of delirium
Shu Xu, Yuanyuan Cui, Jinhua Shen, et al.
Medicine (2020) Vol. 99, Iss. 30, pp. e21043-e21043
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Hypocretins (orexins): The ultimate translational neuropeptides
Laura H. Jacobson, Daniël Hoyer, Luı́s de Lecea
Journal of Internal Medicine (2022) Vol. 291, Iss. 5, pp. 533-556
Closed Access | Times Cited: 71

Delirium: A Marker of Vulnerability in Older People
Giuseppe Bellelli, Justin Brathwaite, Paolo Mazzola
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 47

Natural products against tau hyperphosphorylation‐induced aggregates: Potential therapies for Alzheimer's disease
Gustavo Basurto‐Islas, Mario Dı́az, Lizeth M. Zavala Ocampo, et al.
Archiv der Pharmazie (2025) Vol. 358, Iss. 1
Open Access

A review of symptom, pathogenesis and treatment characteristics of the elderly with chronic insomnia
LiBo Xia, Haiyan Liu, Jixiang Ren
Medicine (2025) Vol. 104, Iss. 5, pp. e41346-e41346
Open Access

Medication-induced causes of delirium in patients with and without dementia: a systematic review of published neurology guidelines
Anita Elaine Weidmann, Guðný Björk Proppé, Rut Matthíasdóttir, et al.
International Journal of Clinical Pharmacy (2025)
Open Access

Translational approaches to influence sleep and arousal
Ritchie E. Brown, Tristan J. Spratt, Gary B. Kaplan
Brain Research Bulletin (2022) Vol. 185, pp. 140-161
Open Access | Times Cited: 17

Suvorexant for Reduction of Delirium in Older Adults After Hospitalization
Kotaro Hatta, Yasuhiro Kishi, Ken Wada, et al.
JAMA Network Open (2024) Vol. 7, Iss. 8, pp. e2427691-e2427691
Open Access | Times Cited: 3

A Rapid Systematic Review of Pharmacologic Sleep Promotion Modalities in the Intensive Care Unit
Mojdeh S. Heavner, Patricia Louzon, Emily Gorman, et al.
Journal of Intensive Care Medicine (2023) Vol. 39, Iss. 1, pp. 28-43
Closed Access | Times Cited: 6

Incremental medical cost of delirium in elderly patients with cognitive impairment: analysis of a nationwide administrative database in Japan
Masakazu Igarashi, Kotoba Okuyama, Naoya Ueda, et al.
BMJ Open (2022) Vol. 12, Iss. 12, pp. e062141-e062141
Open Access | Times Cited: 10

Clinical Evaluation of Sleep Disorders in Parkinson’s Disease
Fulvio Lauretani, Crescenzo Testa, Marco Salvi, et al.
Brain Sciences (2023) Vol. 13, Iss. 4, pp. 609-609
Open Access | Times Cited: 5

Delir und Schlafstörungen − eine Übersichtsarbeit
Julian Kuhlmann, Eman Alhammadi, Anica Mevissen, et al.
Zeitschrift für Gerontologie und Geriatrie (2023) Vol. 56, Iss. 7, pp. 539-544
Closed Access | Times Cited: 5

Pharmacological Management of Sleep–Wake Disturbances in Delirium
Erik A. Levinsohn, Varsha Radhakrishnan, Haley Euting, et al.
The Journal of Clinical Pharmacology (2024)
Closed Access | Times Cited: 1

Acceptability of transdermal antipsychotic patches by patients who refuse oral medication and their effectiveness in preventing recurrence of delirium: a retrospective observational study
Kotaro Hatta, Chie Usui, Hiroyuki Nakamura
International Clinical Psychopharmacology (2022) Vol. 38, Iss. 1, pp. 23-27
Open Access | Times Cited: 6

Suvorexant with or without ramelteon to prevent delirium: a systematic review and meta‐analysis
Yu Tian, Zaisheng Qin, Yunyang Han
Psychogeriatrics (2021) Vol. 22, Iss. 2, pp. 259-268
Closed Access | Times Cited: 8

What evidence is there for implicating the brain orexin system in neuropsychiatric symptoms in dementia?
Giorgio Bergamini, Preciosa Coloma, Helene Massinet, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 4

Use of Suvorexant and Antipsychotics in the Treatment of Delirium After Infectious Diseases
Kazumaro Okino, Hiroki Yamada, Hiroi Tomioka, et al.
Journal of Clinical Psychopharmacology (2021) Vol. 41, Iss. 5, pp. 589-593
Closed Access | Times Cited: 4

Preventive Effects of Ramelteon, Suvorexant, and Lemborexant on Delirium in Hospitalized Patients With Physical Disease
R. Henmi, Tomoyuki Nakamura, Masaya Mashimoto, et al.
Journal of Clinical Psychopharmacology (2024)
Closed Access

Novel applications of sleep pharmacology as delirium therapeutics
Mark Oldham, Adam P. Spira, Michael Yurcheshen, et al.
Sleep Medicine Reviews (2024) Vol. 79, pp. 102016-102016
Closed Access

Suvorexant Poisoning in a Patient With Cirrhosis and Renal Failure
Hiroshi Ito, Yasuhiro Ogawa, Nobutake Shimojo, et al.
Cureus (2021)
Open Access | Times Cited: 3

Reducing the effect of immortal time bias affects the analysis of prevention of delirium by suvorexant in critically ill patients: A retrospective cohort study
Junji Shiotsuka, Shigehiko Uchino, Yusuke Sasabuchi, et al.
PLoS ONE (2022) Vol. 17, Iss. 12, pp. e0277916-e0277916
Open Access | Times Cited: 2

Le syndrome confusionnel en gériatrie
Éric Maeker, Bérengère Maeker-Poquet
NPG. Neurologie, psychiatrie, gériatrie/NPG (2021) Vol. 21, Iss. 122, pp. 68-94
Closed Access | Times Cited: 2

Page 1 - Next Page

Scroll to top